Clinical Trials Archive - Page 13 of 16

recruiting PHASE4 Cardiology / Cardiovascular NCT07053423

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

LPS18583 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 4 study with 2 treatment groups. The purpose of this study is to assess the effect of dupilumab compared with placebo…

Sponsor: Sanofi

View Trial ClinicalTrials.gov ↗

recruiting PHASE3 Oncology NCT06765109

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Multicenter, randomized, controlled, open-label, Phase 3 study designed to demonstrate that neladalkib (NVL-655) is superior to alectinib in prolonging progression-free survival (PFS) in patients with treatment-naïve, Anaplastic Lymphoma Kinase (ALK)…

Sponsor: Nuvalent Inc.

View Trial ClinicalTrials.gov ↗

recruiting PHASE1 Oncology NCT06780137

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Researchers are looking for new ways to treat people with extensive-stage small cell lung cancer (SCLC) that has relapsed or is refractory. Gocatamig is a new type of immunotherapy that…

Sponsor: Merck Sharp & Dohme LLC

View Trial ClinicalTrials.gov ↗

recruiting PHASE3 Cardiology / Cardiovascular NCT05099770

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.

Sponsor: Prokidney

View Trial ClinicalTrials.gov ↗

recruiting PHASE3 Oncology NCT07232719

A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

The purpose of this study is to evaluate the efficacy and safety of retatrutide compared with placebo for body weight reduction. Participation in the study will last about 65 weeks…

Sponsor: Eli Lilly and Company

View Trial ClinicalTrials.gov ↗

recruiting Respiratory / COPD / Asthma NCT05754567

CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes

Neurodevelopmental Outcomes among Offspring of women with Type 1 Diabetes: A Follow up Study of the CONCEPTT Randomized Control Trial (CONCEPTT Kids International). An international, multicentre prospective cohort study of…

Sponsor: University of Manitoba

View Trial ClinicalTrials.gov ↗

recruiting PHASE3 Cardiology / Cardiovascular NCT07222137

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk to develop…

Sponsor: Eli Lilly and Company

View Trial ClinicalTrials.gov ↗

recruiting PHASE3 Cardiology / Cardiovascular NCT07321886

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

The purpose of this study is to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight who do not have type 2 diabetes. The study has…

Sponsor: Eli Lilly and Company

View Trial ClinicalTrials.gov ↗

recruiting NA Diabetes / Metabolic NCT07051005

Feasibility of a Tailored Online Self-compassion Intervention

The goal of this clinical trial is to examine the feasibility and acceptability of an online programme that is based on Compassionate Mind Training (CMT) over four-weeks. The programme intends…

Sponsor: Canterbury Christ Church University

View Trial ClinicalTrials.gov ↗

recruiting PHASE1 Respiratory / COPD / Asthma NCT06637371

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

The main objective of this study is to assess the safety and tolerability of AMG 691 as single doses (healthy participants only) and multiple doses in healthy participants and participants…

Sponsor: Amgen

View Trial ClinicalTrials.gov ↗

Clinical Trials

Join 10,000+ UK Clinicians